Reply To: Traders Market Weekly: Is the Goldilocks Scenario a Myth and Does it Matter?

#64670
Truman
Participant

Horizon Therapeutics plc (HZNP 112.25, +5.58, +5.2%): FTC files motion to withdraw matter from adjudication regarding Amgen (AMGN) deal for HZNP